396 related articles for article (PubMed ID: 11010827)
1. Management of adverse reactions to bacille Calmette-Guérin vaccine.
FitzGerald JM
Clin Infect Dis; 2000 Sep; 31 Suppl 3():S75-6. PubMed ID: 11010827
[TBL] [Abstract][Full Text] [Related]
2. Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccination against tuberculosis in humans, veterinary animals and wildlife species.
Murphy D; Corner LA; Gormley E
Tuberculosis (Edinb); 2008 Jul; 88(4):344-57. PubMed ID: 18222731
[TBL] [Abstract][Full Text] [Related]
3. [HIV-infection, AIDS and BCG vaccination].
Toida I
Kekkaku; 1993 Jun; 68(6):435-44. PubMed ID: 8341039
[TBL] [Abstract][Full Text] [Related]
4. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us?
Menzies D
Clin Infect Dis; 2000 Sep; 31 Suppl 3():S71-4. PubMed ID: 11010826
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects of bacille Calmette-Guerin vaccination in HIV-positive infants.
Hussey G; Hawkridge T; Eley B; Nuttall J; Kibel M; Geiter L; Barker L; Behr M; Demers AM
Clin Infect Dis; 2004 May; 38(9):1333-4; author reply 1334-5. PubMed ID: 15127353
[No Abstract] [Full Text] [Related]
6. National study of adverse reactions after vaccination with bacille Calmette-Guérin.
Turnbull FM; McIntyre PB; Achat HM; Wang H; Stapledon R; Gold M; Burgess MA
Clin Infect Dis; 2002 Feb; 34(4):447-53. PubMed ID: 11797170
[TBL] [Abstract][Full Text] [Related]
7. The effect of Bacille Calmette-Guérin vaccine on tuberculin reactivity in indigenous children from communities with high prevalence of tuberculosis.
Araujo Z; de Waard JH; de Larrea CF; Borges R; Convit J
Vaccine; 2008 Oct; 26(44):5575-81. PubMed ID: 18723065
[TBL] [Abstract][Full Text] [Related]
8. Criteria for discontinuation of vaccination programmes using Bacille Calmette-Guerin (BCG) in countries with a low prevalence of tuberculosis. A statement of the International Union Against Tuberculosis and Lung Disease.
Tuber Lung Dis; 1994 Jun; 75(3):179-80. PubMed ID: 7919307
[No Abstract] [Full Text] [Related]
9. No adverse events after simultaneous administration of 50 000 IU vitamin A and Bacille Calmette-Guerin vaccination to normal-birth-weight newborns in Guinea-Bissau.
Nante JE; Diness BR; Ravn H; Roth A; Aaby P; Benn CS
Eur J Clin Nutr; 2008 Jul; 62(7):842-8. PubMed ID: 17538544
[TBL] [Abstract][Full Text] [Related]
10. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.
Hesseling AC; Rabie H; Marais BJ; Manders M; Lips M; Schaaf HS; Gie RP; Cotton MF; van Helden PD; Warren RM; Beyers N
Clin Infect Dis; 2006 Feb; 42(4):548-58. PubMed ID: 16421800
[TBL] [Abstract][Full Text] [Related]
11. Adverse events following immunisation with bacille Calmette-Guérin vaccination: baseline data to inform monitoring in Australia following introduction of new unregistered BCG vaccine.
Hendry AJ; Dey A; Beard FH; Khandaker G; Hill R; Macartney KK
Commun Dis Intell Q Rep; 2016 Dec; 40(4):E470-E474. PubMed ID: 28043221
[TBL] [Abstract][Full Text] [Related]
12. [Recent problem of skin lesions induced by BCG vaccination].
Mori T; Yamauchi Y
Kekkaku; 2009 Mar; 84(3):109-15. PubMed ID: 19364042
[TBL] [Abstract][Full Text] [Related]
13. An analysis of some hypotheses related to the Chingelput bacille Calmette-Guérin trial.
Smith D; Wiegeshaus E; Balasubramanian V
Clin Infect Dis; 2000 Sep; 31 Suppl 3():S77-80. PubMed ID: 11010828
[TBL] [Abstract][Full Text] [Related]
14. The rate of adverse events following BCG vaccination in Poland.
Krysztopa-Grzybowska K; Paradowska-Stankiewicz I; Lutyńska A
Przegl Epidemiol; 2012; 66(3):465-9. PubMed ID: 23230718
[TBL] [Abstract][Full Text] [Related]
15. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
Szczuka I
Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
[TBL] [Abstract][Full Text] [Related]
16. Influence of BCG vaccine strain on the immune response and protection against tuberculosis.
Ritz N; Hanekom WA; Robins-Browne R; Britton WJ; Curtis N
FEMS Microbiol Rev; 2008 Aug; 32(5):821-41. PubMed ID: 18616602
[TBL] [Abstract][Full Text] [Related]
17. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
[TBL] [Abstract][Full Text] [Related]
18. Bilateral optic neuritis following bacille Calmette-Guérin (BCG) vaccination.
Yen MY; Liu JH
J Clin Neuroophthalmol; 1991 Dec; 11(4):246-9. PubMed ID: 1838542
[TBL] [Abstract][Full Text] [Related]
19. Disseminated Bacille Calmette-Guerin (BCG) disease in an infant with severe combined immunodeficiency.
Sohail S; Afzal M; Anwar V; Shama Q
J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S259-61. PubMed ID: 25518795
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous complication after BCG vaccination: case report and review of the literature.
Keijsers RR; Bovenschen HJ; Seyger MM
J Dermatolog Treat; 2011 Dec; 22(6):315-8. PubMed ID: 20964574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
